Prosight Management, LP
Top Portfolio Positions
46 positions ·
$609,819,830 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| NKTR |
Nektar Therapeutics
Healthcare
|
735,000 | $52,883,250 | 8.67% | |
| BSX |
Boston Scientific Corp
Healthcare
|
795,547 | $49,920,574 | 8.19% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
3,550,000 | $49,345,000 | 8.09% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
1,945,000 | $48,644,450 | 7.98% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
1,550,000 | $46,500,000 | 7.63% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
523,463 | $33,616,793 | 5.51% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
5,004,439 | $32,178,542 | 5.28% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
8,300,000 | $31,125,000 | 5.10% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
3,356,700 | $27,289,971 | 4.48% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
76,000 | $25,146,120 | 4.12% |
Portfolio Trend
25 quarters · across all stocks
Holdings in LKFT
Shares Held
Position Value (USD)
21 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,500,000 | 1,550,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,123,462 | 1,074,112 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $39,836,000 | 1,150,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $49,644,435 | 1,773,649 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,030,237 | 1,314,898 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,187,500 | 1,025,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,620,389 | 1,028,843 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,452,504 | 1,349,980 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,994,686 | 931,512 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,629,501 | 827,294 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,228,651 | 730,207 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,975,550 | 417,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,509,320 | 375,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,636,700 | 465,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,269,200 | 405,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,590,200 | 369,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $23,195,480 | 374,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $19,069,467 | 345,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,188,274 | 250,680 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,960,080 | 72,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,120,240 | 66,419 | Shares | Sole | 2021-05-14 | |
| No 13F history on record for this holder in this stock. | ||||||